Matches in Wikidata for { <http://www.wikidata.org/entity/Q58352581> ?p ?o ?g. }
Showing items 1 to 50 of
50
with 100 items per page.
- Q58352581 description "article scientifique publié en 1992" @default.
- Q58352581 description "im Jahr 1992 veröffentlichter wissenschaftlicher Artikel" @default.
- Q58352581 description "wetenschappelijk artikel" @default.
- Q58352581 description "наукова стаття, опублікована в січні 1992" @default.
- Q58352581 name "CHLORPROMAZINE ENHANCEMENT OF EPIRUBICIN CYTOTOXITY IN VITRO: EFFECTS ON PLASMA MEMBRANE AND DNA DAMAGE" @default.
- Q58352581 name "CHLORPROMAZINE ENHANCEMENT OF EPIRUBICIN CYTOTOXITY IN VITRO: EFFECTS ON PLASMA MEMBRANE AND DNA DAMAGE" @default.
- Q58352581 type Item @default.
- Q58352581 label "CHLORPROMAZINE ENHANCEMENT OF EPIRUBICIN CYTOTOXITY IN VITRO: EFFECTS ON PLASMA MEMBRANE AND DNA DAMAGE" @default.
- Q58352581 label "CHLORPROMAZINE ENHANCEMENT OF EPIRUBICIN CYTOTOXITY IN VITRO: EFFECTS ON PLASMA MEMBRANE AND DNA DAMAGE" @default.
- Q58352581 prefLabel "CHLORPROMAZINE ENHANCEMENT OF EPIRUBICIN CYTOTOXITY IN VITRO: EFFECTS ON PLASMA MEMBRANE AND DNA DAMAGE" @default.
- Q58352581 prefLabel "CHLORPROMAZINE ENHANCEMENT OF EPIRUBICIN CYTOTOXITY IN VITRO: EFFECTS ON PLASMA MEMBRANE AND DNA DAMAGE" @default.
- Q58352581 P1433 Q58352581-D81D3620-BA1F-48EE-A7F8-BD5716D18653 @default.
- Q58352581 P1476 Q58352581-C7AA25FC-E5F3-4E53-901F-99FA768AD75F @default.
- Q58352581 P2093 Q58352581-15233F6A-F9E8-44F7-8333-E24737FB5580 @default.
- Q58352581 P2093 Q58352581-CF17A9FD-CB88-4085-AD99-7205F30ED31B @default.
- Q58352581 P2860 Q58352581-0E8A8E9C-BB5E-4025-B889-8C7E9DC8D9AC @default.
- Q58352581 P2860 Q58352581-26EE2AB6-9A5A-4284-B95D-74CB87CF9CDB @default.
- Q58352581 P2860 Q58352581-2D198E12-E15C-4B79-BFDC-0E04DE38A436 @default.
- Q58352581 P2860 Q58352581-3362D50D-563E-41F6-AC0E-046A99B39B80 @default.
- Q58352581 P2860 Q58352581-3DA0EED3-1684-41F6-BC30-AE3BE0C9F4DB @default.
- Q58352581 P2860 Q58352581-88189605-BC68-427E-9AF9-4F011C51679B @default.
- Q58352581 P2860 Q58352581-CB88CF98-98DC-459B-AD34-35B9B4A3DA36 @default.
- Q58352581 P2860 Q58352581-F9CAC554-2589-4A34-9EDD-4EF20096F66C @default.
- Q58352581 P31 Q58352581-AB253954-CD9D-476C-8018-EA0A8641DE32 @default.
- Q58352581 P356 Q58352581-E5ADD315-93C9-487E-89EA-9821844FBAFB @default.
- Q58352581 P433 Q58352581-403D2D3D-3F30-43E9-97A9-BA08D691A004 @default.
- Q58352581 P478 Q58352581-F8D09B4B-0478-4C32-87AF-5C1A3720E142 @default.
- Q58352581 P50 Q58352581-43B0631D-59D5-4818-A95E-00A6D364329F @default.
- Q58352581 P577 Q58352581-DB2529FA-FF5E-4FCA-81FC-7189251A11D7 @default.
- Q58352581 P921 Q58352581-3435BF97-D11D-455C-B907-29863E29F096 @default.
- Q58352581 P356 DMDI.1992.10.1-2.169 @default.
- Q58352581 P1433 Q23933852 @default.
- Q58352581 P1476 "CHLORPROMAZINE ENHANCEMENT OF EPIRUBICIN CYTOTOXITY IN VITRO: EFFECTS ON PLASMA MEMBRANE AND DNA DAMAGE" @default.
- Q58352581 P2093 "Parviz Behnam Mothlagh" @default.
- Q58352581 P2093 "Roger Henriksson" @default.
- Q58352581 P2860 Q24681984 @default.
- Q58352581 P2860 Q35116324 @default.
- Q58352581 P2860 Q36188362 @default.
- Q58352581 P2860 Q40272321 @default.
- Q58352581 P2860 Q41739717 @default.
- Q58352581 P2860 Q43630262 @default.
- Q58352581 P2860 Q54473976 @default.
- Q58352581 P2860 Q58352754 @default.
- Q58352581 P31 Q13442814 @default.
- Q58352581 P356 "10.1515/DMDI.1992.10.1-2.169" @default.
- Q58352581 P433 "1-2" @default.
- Q58352581 P478 "10" @default.
- Q58352581 P50 Q40580136 @default.
- Q58352581 P577 "1992-01-01T00:00:00Z" @default.
- Q58352581 P921 Q407972 @default.